PDB46 EVALUATING THE LONG-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
May 1, 2019, 00:00
10.1016/j.jval.2019.04.596
https://www.valueinhealthjournal.com/article/S1098-3015(19)30788-0/fulltext
Title :
PDB46 EVALUATING THE LONG-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30788-0&doi=10.1016/j.jval.2019.04.596
First page :
Section Title :
Open access? :
No
Section Order :
10222